下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>

Asian ADRs Move Lower in Friday Trading
亚洲ADR在周五交易中走低

MT Newswires ·  {{timeTz}}

11:01 AM EDT, 09/17/2021 (MT Newswires) -- American depositary receipts of Asian stocks were trading 0.8% lower at 1,997.49 on the S&P/BNY Mellon Asia 50 ADR Index on Friday.

美国东部时间2021年9月17日上午11:01(MT Newswres)-周五,S&P/BNY Mellon Asia 50 ADR指数中,亚洲股票的美国存托凭证(ADR)下跌0.8%,至1,997.49点。

In North Asia, the gainers were led by personal finance company X Financial (XYF) and biopharmaceutical firm BeiGene (BGNE), which climbed 7.3% and 5.1%, respectively. They were followed by wealth management firm Puyi (PUYI) and solar equipment maker ReneSola (SOL), which rose 4.8% and 3.9%, respectively.

在北亚,涨幅最大的是个人理财公司小赢科技和生物制药公司百济神州,这两家公司的股价分别上涨了7.3%和5.1%。紧随其后的是财富管理公司普益(Puyi)和太阳能设备制造商瑞能新能源(Sol),分别上涨4.8%和3.9%。

The decliners in North Asia were led by semiconductor companies Himax Technologies (HIMX) and ASE Technology (ASE), which declined 5% and 3.9%, respectively. Digital finance platform 360 DigiTech (QFIN) was also down 3.6%, while online financial information and service company China Finance Online (JRJC) lost 3.5%.

北亚股市跌幅最大的是半导体公司奇景光电(Starbucks)和日月光半导体(Sequoia Capital),这两家公司分别下跌了5%和3.9%。数字金融平台360数科也下跌了3.6%,在线金融信息和服务公司金融界下跌了3.5%。

In South Asia, the only gainers were biotech firm ASLAN Pharmaceuticals (ASLN) and telecommunications operator Telekomunikas Indonesia (TLK), which gained 1.7% and 0.4%, respectively.

在南亚,唯一的涨幅是生物技术公司Aslan PharmPharmticals(ASLN)和电信运营商Telekomunikas印度尼西亚(TLK),分别上涨1.7%和0.4%。

The decliners in South Asia were led by mining firm Vedanta (VEDL) and telecommunications operator PLDT (PHI), which lost 3.9% and 2.1%, respectively. Bank holding company ICICI Bank Ltd. (IBN) was also down 2%, while automaker Tata Motors (TTM) lost 1.5%.

南亚股市跌幅最大的是矿业公司韦丹塔(Vedanta)和电信运营商PHI,分别下跌3.9%和2.1%。银行控股公司印度工业信贷投资银行也下跌了2%,汽车制造商塔塔汽车(Tata Motors)下跌了1.5%。

本页的译文内容由软件翻译。富途将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。

风险提示:以上内容仅作为作者或者嘉宾的观点,不代表富途的任何立场,不构成与富途相关的任何投资建议。在作出任何投资决定前,投资者应根据自身情况考虑投资产品相关的风险因素,并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性,对此富途不做任何保证和承诺。

回到顶部